The company's principal activities are the development, production, marketing and distribution of a portfolio of minimally-invasive medical devices for the treatment of urological diseases. the company has a direct sales and service force in france, italy, the united states, japan, south korea and malaysia and markets its products through distributors in several other countries. sale of spare parts, supplies and services accounted for 55% of 2001 revenues; Sale of medical devices, 45%.